• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of tumor-specific innovative drug Metformin for gastric cancer cell lines

Research Project

Project/Area Number 15K10008
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Radiation science
Research InstitutionKeio University

Principal Investigator

Shigematsu Naoyuki  慶應義塾大学, 医学部(信濃町), 教授 (30178868)

Co-Investigator(Kenkyū-buntansha) 深田 淳一  慶應義塾大学, 医学部(信濃町), 講師 (50338159)
川田 哲也  慶應義塾大学, 医学部(信濃町), 共同研究員 (60234077)
Project Period (FY) 2015-04-01 – 2018-03-31
Project Status Completed (Fiscal Year 2017)
Budget Amount *help
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2016: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywords放射線治療 / 放射線生物学 / 放射線増感剤 / 胃癌 / 放射線照射 / メトフォルミン
Outline of Final Research Achievements

Treatment results of gastric cancer in advanced stages need improvement. More effective anti-tumor radiosensitizing drug is anticipating. We selected metformin which is one of oral diabetes drugs as a promising radiosensitizer. Treatment effectiveness is assessed by irradiation, drug exposure alone and concomitant use of irradiation and drug in human gastric cell lines. Cell survival was evaluated with colony formation. Apoptosis and cell cycle distribution was evaluated using flow cytometric analyses. Combined therapy showed larger cytotoxic effect and higher apoptotic rate than the other exposure. The G2/G1 ratio was elevated and continued in 72-hours by combined therapy. Metformin showed not only cytotoxic effect but radiosensitizing effect in terms of arresting cell cycle in G2/M phase.

Report

(4 results)
  • 2017 Annual Research Report   Final Research Report ( PDF )
  • 2016 Research-status Report
  • 2015 Research-status Report
  • Research Products

    (9 results)

All 2017 2016 2015

All Journal Article (2 results) (of which Peer Reviewed: 2 results,  Open Access: 1 results) Presentation (7 results) (of which Int'l Joint Research: 4 results)

  • [Journal Article] Long-term Clinical Results of Concurrent Chemoradiotherapy for Patients with Cervical Esophageal Squamous Cell Carcinoma.2017

    • Author(s)
      Atsuhiro Kumabe, Sadatomo Zenda, Atsushi Motegi, Masakatsu Onozawa, Naoki Nakamura, Takashi Kojima, Hiroyuki Daiko, Naoyuki Shigematsu, and Tetsuo Akimoto
    • Journal Title

      Anticancer Res

      Volume: 37(9) Issue: 9 Pages: 5039-5044

    • DOI

      10.21873/anticanres.11919

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Long-term results of concurrent chemoradiotherapy with daily-low-dose continuous infusion of 5-fluorouracil and cisplatin (LDFP) for Stage I-II esophageal carcinoma2017

    • Author(s)
      Kumabe A、Fukada J、Kota R、Koike N、Shiraishi Y、Seki S、Yoshida K、Kitagawa Y、Shigematsu N
    • Journal Title

      Diseases of the Esophagus

      Volume: 31 Issue: 4 Pages: 1-8

    • DOI

      10.1093/dote/dox138

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed
  • [Presentation] ステージI-II期食道癌に対する化学放射線療法2017

    • Author(s)
      外山弘文、深田淳一、隈部篤寛、公田龍一、小池直義、白石悠、北川雄光、茂松直之
    • Organizer
      日本放射線腫瘍学会第30回学術大会
    • Related Report
      2017 Annual Research Report
  • [Presentation] Pleural and pericardial effusion after chemoradiotherapy in esophageal cancer patients. A predictive modeling using mean pericardial irradiated dose2016

    • Author(s)
      J. Fukada, T. Abe, A. Kumabe, H. Takaishi, Y. Kitagawa,N. Shigematsu
    • Organizer
      57th Annual Meeting of American Society for Therapeutic Radiology and Oncology
    • Place of Presentation
      ボストン(アメリカ合衆国)
    • Year and Date
      2016-09-25
    • Related Report
      2016 Research-status Report
    • Int'l Joint Research
  • [Presentation] PI3K/AKT/mTOR inhibitors enhance cytotoxic effect in combination with radiotherapy in gastric cancer cell lines2015

    • Author(s)
      深田淳一, 公田龍一, 三島眞代, 川田哲也, 茂松直之
    • Organizer
      日本放射線腫瘍学会第28回学術大会
    • Place of Presentation
      ベイシア文化ホール(群馬県前橋市)
    • Year and Date
      2015-11-19
    • Related Report
      2015 Research-status Report
  • [Presentation] 食道癌化学放射線治療後の心嚢水・胸水貯留-平均心嚢照射線量を用いた予測モデル-2015

    • Author(s)
      深田淳一,阿部貴行,隈部篤寛,高石官均,北川雄光,茂松直之
    • Organizer
      第53回癌治療学会
    • Place of Presentation
      国立京都国際会館(京都府京都市)
    • Year and Date
      2015-10-29
    • Related Report
      2015 Research-status Report
  • [Presentation] Cytogenetic Effects of Radiation and Caffeine on Normal Human Fibroblast and Ataxia Telangiectasia Heterozygous Fibroblast Cells2015

    • Author(s)
      Shigematsu N, Fukada J, Kota R, Shiraishi Y, Kawata T
    • Organizer
      International congress of Radiation Research
    • Place of Presentation
      国立京都国際会館(京都府京都市)
    • Year and Date
      2015-05-25
    • Related Report
      2015 Research-status Report
    • Int'l Joint Research
  • [Presentation] Chromosomal Aberrations in Normal and AT Cells Exposed to High Dose of Low-dose-rate Irradiation2015

    • Author(s)
      Kawata T, Liu C, Fukada J, Kota R, Shigematsu N
    • Organizer
      International congress of Radiation Research
    • Place of Presentation
      国立京都国際会館(京都府京都市)
    • Year and Date
      2015-05-25
    • Related Report
      2015 Research-status Report
    • Int'l Joint Research
  • [Presentation] adiosensitization in gastric cancer cell lines using different PI3K/AKT/mTOR inhibitors2015

    • Author(s)
      Fukada J, Kota R, Mishima M, Kawata T, Shigematsu N
    • Organizer
      International congress of Radiation Research
    • Place of Presentation
      国立京都国際会館(京都府京都市)
    • Year and Date
      2015-05-25
    • Related Report
      2015 Research-status Report
    • Int'l Joint Research

URL: 

Published: 2015-04-16   Modified: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi